Rituximab use in adult glomerulopathies and its rationale

Glomerulopathies are one of the leading causes of end-stage renal disease. In the last years, clinical research has made significant contributions to the understanding of such conditions. Recently, rituximab (RTX) has appeared as a reasonably safe treatment. The Kidney Disease: Improving Global Outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Joana Eugénio, Fiel, David, Santos, Ricardo, Vicente, Rita, Aguiar, Rute, Santos, Iolanda, Amoedo, Manuel, Pires, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213927/
https://www.ncbi.nlm.nih.gov/pubmed/31904761
http://dx.doi.org/10.1590/2175-8239-JBN-2018-0254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213927/
https://www.ncbi.nlm.nih.gov/pubmed/31904761
http://dx.doi.org/10.1590/2175-8239-JBN-2018-0254

Ejemplares similares